Physician profile
Hasnain Hasham
NPI 1336568369
$34,374.20
in general payments reported to CMS, 2019-2025
26 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $514 · 2021: $263 · 2022: $839 · 2023: $5,654 · 2024: $16K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $6,860 · Food and Beverage: $4,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,000.00 |
| Travel and Lodging | $6,860.43 |
| Food and Beverage | $4,916.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $22,594.99 | 2019-2025 | Indigo System, Ruby Coil, Penumbra Coil 400 |
| Sirtex Medical INC | $9,131.44 | 2024 | Sir-Spheres Microspheres |
| Terumo Medical Corporation | $515.57 | 2019-2022 | |
| Balt USA, LLC | $254.78 | 2023-2024 | Prestige Coil System |
| Cook Medical LLC | $190.56 | 2020-2024 | Zilver Ptx |
| Bard Peripheral Vascular, INC. | $187.76 | 2020-2021 | |
| Stryker Corporation | $176.89 | 2019-2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Argon Medical Devices, INC. | $175.09 | 2019 | |
| Inari Medical, INC. | $151.69 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biocompatibles, INC. | $147.02 | 2019 | |
| Boston Scientific Corporation | $145.25 | 2020-2025 | Embold Fibered |
| Cardiovascular Systems INC. | $98.20 | 2020 | |
| Radius Health, INC. | $88.22 | 2021 | |
| Cordis US Corp. | $85.35 | 2025 | Mynx Control |
| Avanos Medical | $84.22 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $52.49 | 2022-2023 | Kengreal, Cleviprex |
| Medtronic, INC. | $46.25 | 2023-2025 | Osteocool Rf Ablation System, Concertotm |
| W. L. Gore & Associates, INC. | $38.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $36.52 | 2023 | Farxiga |
| Asahi Intecc USA, INC. | $36.25 | 2025 | Asahi Interventional Radiology Wires |
| Imperative Care, INC | $34.54 | 2025 | Zoom 88-T Large Distal Platform |
| Abbott Laboratories | $26.12 | 2024 | Diamondback Peripheral |
| Qapel Medical INC | $24.61 | 2024 | |
| Trisalus Life Sciences, INC. | $22.61 | 2025 | Trinav Infusion System |
| Angiodynamics, INC. | $14.84 | 2023 | Accuvu |
| Teleflex LLC | $14.17 | 2023 | Trapliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasnain Hasham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.